Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F67M6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,055
Award facts
- Contract value 100% obligated
- $55,055.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $55,055.08 firm fixed-price delivery order by the Defense Logistics Agency on February 4, 2026, for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulation. This is a non-set-aside award, meaning it was competitively procured through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying comprehensive medical commodities across multiple therapeutic domains to military and veteran healthcare systems.
This delivery order is executed under Cencora, Inc.'s existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 31, 2031. This prime IDC vehicle serves as the overarching mechanism for delivering pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies. The strategic relationship between the Defense Logistics Agency and Amerisourcebergen Drug Corp demonstrates the contractor's significant role in sustaining pharmaceutical supply chains for the Department of Defense and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F67M6?
SPE2DR26F67M6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F67M6 worth?
The government has obligated $55,055 on SPE2DR26F67M6.
Is contract SPE2DR26F67M6 an order under another contract?
Yes. SPE2DR26F67M6 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F67M6 competed?
The extent of competition for SPE2DR26F67M6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award